refractory indolent NHL

Related by string. * Refractory : relapsed refractory multiple myeloma . refractory Hodgkin lymphoma . relapsed refractory AML . hormone refractory prostate cancer . refractory anemia / Indolent : indolent follicular non . quintessential indolent American . indolent NHL . line Indolent Trial / NHLS . nhl . Nhl . NHLer : Terry Sawchuk NHL . NHL Capsules . NHL Entry Draft . 2K Sports NHL #K# * *

Related by context. Frequent words. (Click for all words.) 62 refractory multiple myeloma 61 relapsed refractory multiple myeloma 59 R sorafenib tablets 58 refractory Hodgkin lymphoma 58 heavily pretreated patients 57 refractory PTCL 57 indolent NHL 57 relapsed 56 lymphoma CTCL 56 advanced carcinoid 56 Amrubicin 56 heavily pretreated 56 forodesine 55 metastatic hormone refractory 55 relapsing multiple sclerosis 55 relapsed refractory 54 refractory peripheral T 54 RRMS patients 54 HER2 positive metastatic breast 54 Epratuzumab 54 cytogenetic response 54 paclitaxel chemotherapy 54 Relapsed 54 HGS ETR1 54 Jevtana 54 docetaxel chemotherapy 54 chlorambucil 54 relapsed multiple myeloma 54 RECIST criteria 54 mucosal healing 54 plus prednisone 53 dacarbazine 53 fitball courses 53 nab paclitaxel 53 DOXIL 53 undetectable HCV RNA 53 plus methotrexate 53 Orphan Drug designation 53 complete remissions 53 BrachySil 53 follicular non 52 TORISEL 52 Taxotere ® 52 goserelin 52 Gemzar ® 52 squalamine 52 multiple myeloma MM 52 Cethrin 52 PEG SN# 52 leukemia CLL 52 vandetanib 52 evaluable patients 52 pseudobulbar affect PBA 52 PREZISTA r 52 mg BID 52 primary hypercholesterolemia 52 superficial bladder cancer 52 plus dexamethasone 52 Irinotecan 52 Eltrombopag 52 sustained virologic response 52 cell chronic lymphocytic 52 elotuzumab 52 EOquin 51 HER2 negative 51 KRN# 51 Pegasys ® 51 Orphan Drug status 51 patients evaluable 51 Fludara 51 TREANDA 51 Alemtuzumab 51 KRAS wild 51 carboplatin paclitaxel 51 mcg kg 51 FOLFIRI 51 KNS # 51 peg IFN 51 biologic therapy 51 Navelbine 51 medullary thyroid cancer 51 abiraterone acetate 51 tumor shrinkage 51 TNF blocking 51 adalimumab 51 dose limiting toxicities 51 acute manic 51 romidepsin 51 metastatic renal cell carcinoma 50 Herceptin trastuzumab 50 registrational 50 orphan designation 50 Bortezomib 50 chronic angina 50 zileuton 50 B CLL 50 acute promyelocytic leukemia APL 50 discontinuations due 50 gastrointestinal stromal tumors GIST 50 valopicitabine 50 tamibarotene

Back to home page